A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2006
12/14/2006	CA2611416A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method for the production thereof
12/14/2006	CA2611401A1 Oxindoles as kinase inhibitors
12/14/2006	CA2610172A1 Heterocyclic compound
12/13/2006	EP1731529A1 Calcium ion leakage inhibitors
12/13/2006	EP1731521A1 Adiponectin increasing agent
12/13/2006	EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006	EP1731516A2 The 9,11-cycloendoperoxide prodrugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
12/13/2006	EP1731502A1 Novel crystal of triterpene derivative
12/13/2006	EP1731168A1 Antibody drug
12/13/2006	EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development
12/13/2006	EP1731161A1 Compositions for the treatment of diseases associated with elevated sphingolipid concentrations
12/13/2006	EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006	EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
12/13/2006	EP1731134A1 Functional powders
12/13/2006	EP1729823A2 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
12/13/2006	EP1729812A1 Stable pharmaceutical composition comprising an ace inhibitor
12/13/2006	EP1729788A1 Restenosis therapy using mesenchymal stem cells
12/13/2006	EP1729761A1 Cadasil treatment with cholinesterase inhibitors
12/13/2006	EP1729752A2 Method for treating aortic stenosis with non-antibacterial tetracycline formulations
12/13/2006	EP1729749A2 Use of renin inhibitors in therapy
12/13/2006	EP1729748A1 Microemulsion preconcentrate comprising a renin inhibitor
12/13/2006	EP1729747A2 Thiol reactive agents as a therapeutic modality
12/13/2006	EP1596856B1 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
12/13/2006	EP1551334A4 Medical device for intra-lumenal delivery of pharmaceutical agents
12/13/2006	EP1446127B1 Triazepine derivatives as neurotrophic agents
12/13/2006	EP1427424A4 Lpa receptor agonists and antagonists and methods of use
12/13/2006	EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006	EP1404853B1 Process for the production of allicin
12/13/2006	EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction
12/13/2006	EP1372737B8 Preparation for the prophylaxis of restenosis
12/13/2006	EP1313488B1 Compositions and methods for improving cardiovascular function
12/13/2006	EP1272219B1 New combination of a betablocker and a cholesterol-lowering agent
12/13/2006	EP1268558B1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
12/13/2006	EP1123392B1 Prv-1 gene and the use thereof
12/13/2006	EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006	EP0883343B1 Compositions for treating ischemic tissue
12/13/2006	CN1878773A Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
12/13/2006	CN1878755A Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
12/13/2006	CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006	CN1878549A Percutaneous absorption type cerebral protective agent
12/13/2006	CN1878545A Thyroid hormone analogs and methods of use
12/13/2006	CN1878544A Use of enos transcription enhancers in the cell therapy of ischemic heart diseases
12/13/2006	CN1878529A Combined cosmetic or therapeutic preparation
12/13/2006	CN1878464A Therapeutic delivery of carbon monoxide
12/13/2006	CN1876818A Recombinant plasmid capable of efficiently expressing human liver growth factor in eukaryotic cell
12/13/2006	CN1876683A Human antibodies that bind human TNFalpha
12/13/2006	CN1876646A Improved cinepazide maleate preparation method
12/13/2006	CN1876641A Method for purifying salvianolic acid B
12/13/2006	CN1876153A A preparation method of medicine for treating hemiparalysis caused by apoplexy
12/13/2006	CN1876146A A Chinese medicine for treating cardiovascular and cerebrovascular disease
12/13/2006	CN1876127A An antihypertensive medicine
12/13/2006	CN1876126A A tujia ethnic minority empirical prescription for treating cardiovascular and cerebrovascular disease
12/13/2006	CN1876125A Medicine for treating cardiovascular and cerebrovascular disease and preparation method thereof
12/13/2006	CN1876123A Collaterals-dredging blood fat-reducing remedy for treating paralysis
12/13/2006	CN1876121A A medicinal wine capable of treating multiple diseases
12/13/2006	CN1876083A A blood circulation-invigorating tendon-strengthening capsule and preparation process thereof
12/13/2006	CN1876078A Chinese medicinal composition capable of protecting vascular endothelial cell function and preparation method thereof
12/13/2006	CN1876033A Compound Chinese preparation with gingko, its preparation method and use
12/13/2006	CN1876032A A medicine for treating coronary atherosclerotic heart disease
12/13/2006	CN1876028A Pharmaceutical preparation for treating coronary heart disease, its preparation process and quality control method
12/13/2006	CN1876023A Use of a kind of Chinese medicine for treating cerebrovascular disease and preparation method thereof
12/13/2006	CN1876022A Pharmaceutical composition with red sage root and Erigeron breviscapus for treating cerebrovascular disease, its preparation process and quality control method
12/13/2006	CN1876004A A medicament for treating cerebrovascular disease
12/13/2006	CN1875997A Application of sundew in pharmaceutical preparation
12/13/2006	CN1875981A Injection emulsion containing breviscapinum and preparation method thereof
12/13/2006	CN1875979A Soft capsule of hippophae rhamnoides and preparation process thereof
12/13/2006	CN1875972A Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology
12/13/2006	CN1875925A Sodium tashinone II A sulfonate injection and preparation method thereof
12/13/2006	CN1875787A Health tea drink of Aizoon stonecrop herb
12/13/2006	CN1289673C Anemone neurotoxin gene Sr6 and application thereof
12/13/2006	CN1289509C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, and pharmaceutical compositions containing same
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006	CN1289500C Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
12/13/2006	CN1289499C Pirazino (aza) indole derivatives
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289485C Preparation of an anhydrous quinoline-based EETP inhibitor by crystallization
12/13/2006	CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006	CN1289482C Organic acid salt of amlodipine
12/13/2006	CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289128C A pharmaceutical composition for treating headache disease, preparation process and uses thereof
12/13/2006	CN1289107C Fig buccal tablet and its preparing process
12/13/2006	CN1289094C 三磷酸腺苷盐组合物 Adenosine triphosphate salt composition
12/13/2006	CN1289093C Breviscapine drop pills and its preparing method
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006	CN1289083C 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
12/13/2006	CN1289080C Vegetable estrogen analogy composition capable of replacing estrogen and its application
12/13/2006	CN1289079C Use of an cactus extract and compounds isolated therefrom for protecting nerve cells
12/13/2006	CN1289074C Method for preparing sodium ferulate sterilized raw-material medicine
12/12/2006	US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148233 Treatment of cardiovascular and related pathologies
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148199 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation

1 ... 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 ... 1595